Bifogade filer
Kurs
+6,55%
Likviditet
0,02 MSEK
Prenumeration
Kalender
Tid* | ||
2026-02-25 | 08:00 | Bokslutskommuniké 2025 |
2025-11-12 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-13 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-14 | N/A | Årsstämma |
2025-05-14 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-26 | 08:00 | Bokslutskommuniké 2024 |
2025-01-20 | - | Extra Bolagsstämma 2025 |
2024-11-13 | - | Kvartalsrapport 2024-Q3 |
2024-08-14 | - | Kvartalsrapport 2024-Q2 |
2024-05-30 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2024-05-29 | - | Årsstämma |
2024-05-15 | - | Kvartalsrapport 2024-Q1 |
2024-04-05 | - | Extra Bolagsstämma 2024 |
2024-02-28 | - | Bokslutskommuniké 2023 |
2023-12-20 | - | Extra Bolagsstämma 2023 |
2023-11-08 | - | Kvartalsrapport 2023-Q3 |
2023-07-24 | - | Kvartalsrapport 2023-Q2 |
2023-05-29 | - | Årsstämma |
2023-05-16 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2023-05-08 | - | Kvartalsrapport 2023-Q1 |
2023-02-15 | - | Bokslutskommuniké 2022 |
2022-11-09 | - | Kvartalsrapport 2022-Q3 |
2022-08-17 | - | Kvartalsrapport 2022-Q2 |
2022-05-16 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2022-05-13 | - | Årsstämma |
2022-05-13 | - | Kvartalsrapport 2022-Q1 |
2022-04-08 | - | Extra Bolagsstämma 2022 |
2022-02-16 | - | Bokslutskommuniké 2021 |
2021-11-10 | - | Kvartalsrapport 2021-Q3 |
2021-08-18 | - | Kvartalsrapport 2021-Q2 |
2021-05-10 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2021-05-07 | - | Årsstämma |
2021-05-07 | - | Kvartalsrapport 2021-Q1 |
2021-02-16 | - | Bokslutskommuniké 2020 |
2020-11-10 | - | Kvartalsrapport 2020-Q3 |
2020-08-18 | - | Kvartalsrapport 2020-Q2 |
2020-06-05 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2020-06-04 | - | Årsstämma |
2020-05-07 | - | Kvartalsrapport 2020-Q1 |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-12-19 | - | Extra Bolagsstämma 2019 |
2019-11-05 | - | Kvartalsrapport 2019-Q3 |
2019-08-13 | - | Kvartalsrapport 2019-Q2 |
2019-05-09 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2019-05-08 | - | Årsstämma |
2019-05-08 | - | Kvartalsrapport 2019-Q1 |
2019-02-12 | - | Bokslutskommuniké 2018 |
2018-11-20 | - | Kvartalsrapport 2018-Q3 |
2018-08-21 | - | Kvartalsrapport 2018-Q2 |
2018-07-25 | - | Extra Bolagsstämma 2018 |
2018-05-09 | - | X-dag ordinarie utdelning SIMRIS B 0.00 SEK |
2018-05-08 | - | Årsstämma |
2018-05-08 | - | Kvartalsrapport 2018-Q1 |
2018-02-20 | - | Bokslutskommuniké 2017 |
2017-11-21 | - | Kvartalsrapport 2017-Q3 |
2017-08-22 | - | Kvartalsrapport 2017-Q2 |
2017-05-11 | - | Årsstämma |
2017-05-11 | - | Kvartalsrapport 2017-Q1 |
2017-04-22 | - | Bokslutskommuniké 2016 |
2016-11-11 | - | Kvartalsrapport 2016-Q3 |
2016-09-21 | - | Extra Bolagsstämma 2016 |
2016-08-24 | - | Kvartalsrapport 2016-Q2 |
2016-05-18 | - | Kvartalsrapport 2016-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Handel & varor |
Industri | Dagligvaror |
Simris Group confirms that 100 % of its upcoming SEK 24,3 million rights issue now is underwritten with 8,8 precent in subscription commitments and 91,2 precent in guarantee commitments.
After resolution on the extraordinary general meeting (EGM), 24 July 2023, a majority of the board members have entered into subscription and guarantee commitments as intended in the press release from 5 July 2023.
The underwriters of the rights issue will, on the same terms as in the rights issue, participate in a directed issue with the corresponding unutilized part of the underwriting commitment, and for an additional SEK 4.4 million as underwriter compensation. The directed issue can amount to a maximum of approximately SEK 26.6 million.
Provided that the rights issue and the directed issue are fully subscribed (which will be the case if the rights issue is fully subscribed without the utilization of the underwriting commitments), the Company will receive proceeds of approximately SEK 51 million before the deduction of transaction costs.
Contact Details:
Julian Read
CEO Simris Group AB
Email: ir@simris.com
Mobile: +46767888212
www.simrisgroup.com
About Simris Group AB (PUBL):
Simris Group is a biologics company identifying high value, natural, biologically active compounds found in microalgae and cyanobacteria to extract for applications in skincare, nutrition, and biopharmaceuticals. The company sustainably grows microalgae and cyanobacteria at industrial scale within its photobioreactor facility whereby conditions are optimized for production of these high-value compounds.
Simris Group's shares are traded on the Nasdaq First North Growth Market with the short name SIMRIS and ISIN code SE0008091664.
Certified Adviser is Amudova AB, telephone: 08-546 017 58, email: info@amudova.se.